Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

AC105 Increases Extracellular Magnesium Delivery and Reduces Excitotoxic Glutamate Exposure within Injured Spinal Cords in Rats.

Huang Z, Filipovic Z, Mp N, Ung C, Troy EL, Colburn RW, Iaci JF, Hackett C, Button DC, Caggiano AO, Parry TJ.

J Neurotrauma. 2017 Feb;34(3):685-694. doi: 10.1089/neu.2016.4607. Epub 2016 Sep 14.

PMID:
27503053
2.

Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy.

Zhang Z, Ding Q, Liu JJ, Zhang J, Jiang N, Chu XJ, Bartkovitz D, Luk KC, Janson C, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev LT, Graves B.

Bioorg Med Chem. 2014 Aug 1;22(15):4001-9. doi: 10.1016/j.bmc.2014.05.072. Epub 2014 Jun 11.

PMID:
24997575
3.

Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development.

Zhang Z, Chu XJ, Liu JJ, Ding Q, Zhang J, Bartkovitz D, Jiang N, Karnachi P, So SS, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev L, Graves B.

ACS Med Chem Lett. 2013 Dec 29;5(2):124-7. doi: 10.1021/ml400359z. eCollection 2014 Feb 13.

4.

Preclinical optimization of MDM2 antagonist scheduling for cancer treatment by using a model-based approach.

Higgins B, Glenn K, Walz A, Tovar C, Filipovic Z, Hussain S, Lee E, Kolinsky K, Tannu S, Adames V, Garrido R, Linn M, Meille C, Heimbrook D, Vassilev L, Packman K.

Clin Cancer Res. 2014 Jul 15;20(14):3742-52. doi: 10.1158/1078-0432.CCR-14-0460. Epub 2014 May 8.

5.

Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Chang YS, Graves B, Guerlavais V, Tovar C, Packman K, To KH, Olson KA, Kesavan K, Gangurde P, Mukherjee A, Baker T, Darlak K, Elkin C, Filipovic Z, Qureshi FZ, Cai H, Berry P, Feyfant E, Shi XE, Horstick J, Annis DA, Manning AM, Fotouhi N, Nash H, Vassilev LT, Sawyer TK.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3445-54. doi: 10.1073/pnas.1303002110. Epub 2013 Aug 14.

6.

Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development.

Ding Q, Zhang Z, Liu JJ, Jiang N, Zhang J, Ross TM, Chu XJ, Bartkovitz D, Podlaski F, Janson C, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev LT, Graves B.

J Med Chem. 2013 Jul 25;56(14):5979-83. doi: 10.1021/jm400487c. Epub 2013 Jul 16.

PMID:
23808545
7.

MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.

Tovar C, Graves B, Packman K, Filipovic Z, Higgins B, Xia M, Tardell C, Garrido R, Lee E, Kolinsky K, To KH, Linn M, Podlaski F, Wovkulich P, Vu B, Vassilev LT.

Cancer Res. 2013 Apr 15;73(8):2587-97. doi: 10.1158/0008-5472.CAN-12-2807. Epub 2013 Feb 11.

8.

Radical retropubic prostatectomy--report on 41 cases.

Colovi V, Hadzi-Djokic J, Filipovic Z, Popovi D, Sola N, Paunkovic P, Masulovic D.

Acta Chir Iugosl. 2005;52(4):75-6.

PMID:
16673600
9.

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.

Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H, Zhao X, Vu BT, Qing W, Packman K, Myklebost O, Heimbrook DC, Vassilev LT.

Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1888-93. Epub 2006 Jan 27.

10.

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA.

Science. 2004 Feb 6;303(5659):844-8. Epub 2004 Jan 2.

11.

Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation.

Yang H, Filipovic Z, Brown D, Breit SN, Vassilev LT.

Mol Cancer Ther. 2003 Oct;2(10):1023-9.

12.

Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock.

Ataman K, Jehmlich M, Kock S, Neumann S, Leischik M, Filipovic Z, Hopf HB.

Intensive Care Med. 2002 Aug;28(8):1164-7. Epub 2002 Jul 5.

PMID:
12185443
13.

Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats.

Kerr SW, Wolyniec WW, Filipovic Z, Nodop SG, Braza F, Winquist RJ, Noonan TC.

J Pharmacol Exp Ther. 1999 Nov;291(2):903-10.

PMID:
10525115
14.

[Immunity in diabetic nephropathy].

Redzepagić B, Macanović M, Hadzimejlić M, Cetinić F, Popadić M, Filipović Z.

Lijec Vjesn. 1984 Nov-Dec;106(11-12):459-62. Croatian. No abstract available.

PMID:
6521602
15.

[Human leukocyte HLA antigen system and diabetes].

Filipović Z.

Med Arh. 1979 Sep-Dec;33(5-6):347-50. Croatian. No abstract available.

PMID:
548684
16.

[Recognition of endocrine polyadenomatosis].

Filipović Z, Filipović A.

Med Arh. 1978 Jul-Aug;32(4):219-24. Croatian. No abstract available.

PMID:
226816
17.

[Diagnostic value of thyroid-gland lymphography].

Filipović Z, Dordević J.

Med Arh. 1977 Jan-Feb;31(1):13-6. Croatian. No abstract available.

PMID:
865148
18.

[Psychoses connected with unknown endocrinopathies--cure by use of hormones (practical and theoretical significance)].

Filipović Z, Filipović A.

Med Arh. 1969 Jul-Aug;23(5):25-34. Croatian. No abstract available.

PMID:
5201550
19.

[ACUTE ADRENAL INSUFFICIENCY DURING ANTICOGULANT THERAPY].

FILIPOVIC Z.

Med Arh. 1965 Mar-Apr;19:43-7. Undetermined Language. No abstract available.

PMID:
14346570
20.

[Contribution to the diagnosis of gynecomastia and its treatment with report of a case].

PRCIC M, FILIPOVIC Z, PROTIC MF.

Med Arh. 1962 Jul-Aug;16:19-28. Undetermined Language. No abstract available.

PMID:
13985991
21.

[Clinical contribution to strongyloidiasis].

FILIPOVIC Z, REZAKOVIC D.

Med Arh. 1961 Sep-Oct;15:21-7. Undetermined Language. No abstract available.

PMID:
13892869
22.

[Acute spontaneous thyroid crisis].

ZARA M, FILIPOVIC Z.

Med Arh. 1959 Nov-Dec;13:69-73. Undetermined Language. No abstract available.

PMID:
13847030
23.

[Successful phenergan therapy of cardiospasm].

FILIPOVIC Z.

Med Arh. 1954 Jul-Aug;8(4):79-81. Undetermined Language. No abstract available.

PMID:
14369451
24.

Diabetes insipidus.

FILIPOVIC Z.

Med Arh. 1954 May-Jun;8(3):71-82. Undetermined Language. No abstract available.

PMID:
13223188

Supplemental Content

Loading ...
Support Center